Insulin Lispro vs Exendin-4

Head-to-head comparison of Insulin Lispro (Insulin lispro (B28-Lys, B29-Pro human insulin analog)) and Exendin-4 (Exendin-4 (synthetic exenatide)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyInsulin LisproExendin-4
CategoryDiabetes & MetabolicDiabetes & Metabolic
Full NameInsulin lispro (B28-Lys, B29-Pro human insulin analog)Exendin-4 (synthetic exenatide)
Molecular Weight5808.0 Da4186 Da
Half-LifeAbout 1 hour2.4 hours
Amino Acids5139
Typical Dose0.05-0.2 U/kg per meal5-10 mcg twice daily
RouteSubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count120001800
Research StatusApprovedClinical

Insulin Lispro Benefits

  • Rapid postprandial glucose control
  • Flexible premeal timing
  • Predictable onset of action
  • Useful in basal-bolus regimens

Exendin-4 Benefits

  • beta-cell survival
  • glucose-stimulated insulin secretion
  • reduced glucolipotoxicity
  • lowered HbA1c in clinical use

Insulin Lispro Dosing

Inject SC 0-15 minutes before meals|Adjust dose to carbohydrate intake and premeal glucose|Often paired with a basal insulin

Exendin-4 Dosing

5 mcg SC twice daily for 4 weeks|increase to 10 mcg SC twice daily if tolerated|research: 0.1-1 µM in vitro or 1-10 µg/kg in animals

Insulin Lispro Side Effects

  • Hypoglycemia
  • Weight gain
  • Injection-site reactions

Exendin-4 Side Effects

  • nausea
  • vomiting
  • injection-site reactions

Research Overview

Insulin Lispro

Clinical studies show faster onset and shorter duration than regular insulin, improving post-meal glucose control. It is a standard comparator in diabetes pharmacology and closed-loop insulin-delivery research.

Exendin-4

Exendin-4 helped establish GLP-1 receptor biology in diabetes and remains a classic beta-cell protective peptide. Preclinical studies show reduced beta-cell apoptosis, improved insulin content, and better islet function under metabolic stress.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Insulin Lispro stacks with:

Insulin GlargineInsulin Degludec

Exendin-4 stacks with:

SGLT2 inhibitorsDPP-4 inhibitorsdiet and exercise
rapid-acting insulinprandial controlglucose regulationGLP-1 agonistbeta-cell protectionincretin